Specialized Consumer Services

Bruce Galloway Holds 8.42% of WW International and Plans to Communicate

WW released FY2026 Q1 earnings on May 7 Pre-Market (EST), actual revenue USD 168.26 M (forecast USD 158.53 M), actual EPS USD -5.202 (forecast USD -2.77)

WW International reports Q1 2026 net loss of $52 million

WW International Plans to Release Q1 2026 Earnings Report

WW to release FY2026 Q1 earnings on May 7 Pre-Market EST, forecast revenue USD 158.53 M, EPS USD -2.77

WW International plans to repay up to $40 million in term loans ahead of schedule

WW International Reports Q3 2025 Earnings with a Loss of $1.04 per Share

WW released FY2025 earnings on March 16 Pre-Market (EST), actual revenue USD 710.64 M (forecast USD 699.71 M), actual EPS USD 11.6063 (forecast USD 6.11)

WW released FY2025 Q4 earnings on March 16 Pre-Market (EST), actual revenue USD 162.81 M (forecast USD 149.8 M), actual EPS USD -0.584 (forecast USD -2.03)

WW International Reports Q4 Revenue Decline But Clinical Subscriptions Revenue Growth

WeightWatchers to Report Q4 Earnings

WW to Release FY2025 Q4 Earnings on March 16, Pre-Market EST; Forecast Revenue USD 149.8 M, EPS USD -2.03

WW International Sees Significant Increase in Short Interest and Rating Downgrades

WW released FY2025 Q3 earnings on November 6 Pre-Market EST, actual revenue USD 172.09 M (forecast USD 161.38 M), actual EPS USD -5.76 (forecast USD -0.65)

WW released FY2025 9 Months Earnings on November 6 Pre-Market (EST), Actual Revenue: USD 172.09 M, Actual EPS: USD -103.1854

WW to release FY2025 Q3 earnings on November 6, Pre-Market EST, forecast revenue USD 161.38 M, EPS USD -0.1

WW International Announces Partnership with Amazon Pharmacy to Enhance Weight Management Medication Accessibility

WW released FY2025 Q2 earnings on August 11 Pre-Market EST, actual revenue USD 189.16 M (forecast USD 178.05 M), actual EPS USD 15.5659 (forecast USD -0.4)

WW released FY2025 Semi-Annual earnings on August 11 Pre-Market (EST), actual revenue USD 375.74M, actual EPS USD 14.2261

WW International reports second-quarter net income of $119.1 million

InMed Pharmaceuticals

AMPLITECH GROUP INC. USD0.001 S/R 20/11/26 SER B

Amesite

CN Energy

AMPLITECH GROUP INC. COM USD0.001 (S/R 18/07/2026)

NextNRG

Meiwu Tech

Generation Income Properties

MetaVia

OceanPal

WGHTQ

Galloway Capital Partners has acquired an 8.42% stake in WW International, asserting that the company is significantly undervalued despite its strong brand and growth in the wellness sector. Following a debt reduction from $1.4 billion to $460 million, WW's market cap has dropped below $100 million. Galloway highlights WW's 50% annual growth in its clinical business and valuable member data. Currently trading at 3.7x EBITDA, Galloway believes WW's true value is much higher and aims to work with the board to enhance shareholder value.

Fidelity

WW INTERNATIONAL INC

Galloway Capital Partners Announces Investment in WW International and Believes Shares Are Worth Multiples of Current Price

Bruce Galloway, through Galloway Capital Partners, LLC and Galloway Capital, LP, has disclosed an 8.42% stake in WW International, Inc. as of May 13, 2026. He intends to engage with the company's leadership on various aspects including performance and governance. Galloway may buy more shares or propose formal actions as he reviews the company's operations and strategy. He is known for targeting small and mid-cap companies to unlock value through operational changes.

TradingView

Bruce Galloway Takes Activist Stake at WW International with 8.42% Stake

WW International shares are trading lower after the company reported mixed Q1 financial results and reaffirmed its FY26 sales guidance with its midpoint below estimates.

benzinga_article

Yesterday's closing price for Weight Watchers was $10.15, down 3.61% from the previous trading day. The MACD indicator shows a death cross signal, indicating a bearish short-term technical outlook, and the unstable market sentiment has increased risk warnings. Trading volume has increased compared to previous periods, but the nature of the funds leans more towards short-term selling. On the news front, despite the stable potential demand in the weight loss and health management market, WTW faces issues of brand aging and unclear product diversification strategies. Industry competition comes not only from traditional weight loss services but also from the ongoing penetration of technology and internet-listed companies. The tense situation in the US-Iran region and uncertainty in major economic activities have led to increased demand for safe-haven assets, coupled with unclear signals of easing from the Federal Reserve's meeting communications, putting pressure on the consumer goods sector. Technical indicators show that the stock price has broken below the horizontal price range formed over the past month; if it falls below the $10 mark again, it may indicate further declines. Recently, the pressure from forced selling has intensified, and the willingness to support buying is weak, creating a negative cycle. The short-term trend is biased towards bearishness, and the impact of diversification and transformation needs to be continuously observed. Investors should pay attention to controlling their positions to manage risk and avoid blindly increasing their holdings. This article is for technical analysis and market information reference only and does not constitute any investment advice

Technical Forecast

Willis Towers Watson

Pre-market trend | Weight Watchers (WTW) on May 1st shows intensified downward momentum, with support line under severe pressure?

Weight Watchers Expands Med+ With Access to New Ozempic® pill (semaglutide) | WW Stock News

StockTitan

Weight Watchers Expands Med+ With Access to New Ozempic® pill (semaglutide) | WW Stock News

WW(WW.US)

Galloway Capital Partners Announces Investment in WW International and Believes Shares Are Worth Multiples of Current Price

Bruce Galloway Takes Activist Stake at WW International with 8.42% Stake

WW International shares are trading lower after the company reported mixed Q1 financial results and reaffirmed its FY26 sales guidance with its midpoint below estimates.

Pre-market trend | Weight Watchers (WTW) on May 1st shows intensified downward momentum, with support line under severe pressure?

Weight Watchers Expands Med+ With Access to New Ozempic® pill (semaglutide) | WW Stock News